Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-400
Closed -$988 700
2025
Q1
$988 Sell
400
-1,500
-79% -$3.57K ﹤0.01% 630
2024
Q4
$5.97K Hold
1,900
﹤0.01% 549
2024
Q3
$9.37K Hold
1,900
﹤0.01% 503
2024
Q2
$8.38K Buy
+1,900
New +$8.9K ﹤0.01% 494

Other funds holding SLRN

BFSG LLC's SLRN Position: Q2 2025 in Review

BFSG LLC sold out of ACELYRIN (SLRN) in Q2 2025, closing a stake of 400 shares — an estimated $988 sold.

BFSG LLC first reported a position in SLRN in Q2 2024 and held it in 4 quarters. The position peaked at $9.37K in Q3 2024. 2 funds tracked by Wall St. Rank hold SLRN as of Q2 2025.

  • BFSG LLC reported no remaining ACELYRIN position as of Q2 2025 after selling out during the quarter.
  • BFSG LLC sold 400 ACELYRIN shares in Q2 2025, an estimated $988.
  • BFSG LLC first reported a position in ACELYRIN in Q2 2024 and held it in 4 quarters.
  • BFSG LLC's ACELYRIN position peaked at $9.37K in Q3 2024.
  • 2 funds tracked by Wall St. Rank held ACELYRIN as of Q2 2025.

Based on BFSG LLC's 13F filing for Q2 2025, filed 15 Jul 2025.